My IDSA Contact Us
IDSA NewsPrint-Friendly Newsletter
Forward to a Friend
Search Back Issues
 
Education & Training Resources Practice Guidlines Journals & Publications Policy & Advocacy Meetings About IDSA
August 2008
Vol. 18 No. 8
IDSA Advocacy Update: Animal Drug Legislation Passes

Congress this month passed legislation requiring drug manufacturers to report to the Food and Drug Administration (FDA) the quantities of antibiotics sold for use in food animals. IDSA was a primary supporter of the provision, found in the Animal Drug User Fee Amendments of 2008.  The provision provides an important step toward better understanding the amounts of antibiotics used in food animals, with the end goal of limiting any negative impacts of such use on human health.

Other advocacy efforts include:

  • The Society asked the FDA to clarify whether the Orphan Drug (OD) Act or a parallel regulatory framework would be an appropriate mechanism to spur research and development of antibacterial therapies and related diagnostics and vaccines for drug-resistant infections.  Previous conflicting comments from FDA officials have caused confusion for policymakers trying to address the problems outlined in IDSA’s 2004 “Bad Bugs, No Drugs” report.
  • IDSA issued a press release opposing the Environmental Protection Agency’s decision to permit the State of Michigan to spray the state’s apple orchards with gentamicin. The Society said this decision risks undermining the value of this important antibiotic to treat blood infections in newborns and other serious human infections.

How useful is this article?

< Previous Article | Next Article >

Post a comment

Your name:

Your comment:


Flu Vaccine Begins Shipping
IDSA Journal Club, August 2008
IDSA News CORRECTION
In the IDSA Journals
EIN: Alternative Dosages for Clinamycin
Drug Approvals, Recalls, Adverse Events Update
Medicare Adds Only One New HAC to the List for Nonpayment in 2009
Plan Your ICAAC/IDSA Conference with the Online Program Planner
IDSA Advocacy Update: Animal Drug Legislation Passes
Applications Being Accepted for Lyme Disease Review Panel
Vote for the IDSA Board of Directors
Members on the Move
Welcome, New IDSA Members!

  

 

IDSA | 1300 Wilson Blvd., Suite 300 | Arlington, VA 22209 | Phone: (703) 299-0200
To ensure delivery, please add 'idsa@idsociety.org' to your email address book or Safe Sender List.
If you are still having problems receiving our communications,
see our white-listing page for more details.